Related Experiment Videos

Reoperative myocardial revascularization: an analysis of 458 reoperations and 2645 single operations

M Schmuziger1, J T Christenson, J Maurice

  • 1Cardiovascular Unit, Hôpital de la Tour, Geneva, Switzerland.

Cardiovascular Surgery (London, England)
|October 1, 1994
PubMed

Insights

Reoperative coronary artery bypass grafting (CABG) is effective but carries higher operative mortality and morbidity than primary CABG. Outcomes worsen with shorter intervals between surgeries, unstable angina, or poor left ventricular function.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Coronary Artery Bypass Grafting

Background:

  • Primary and reoperative coronary artery bypass grafting (CABG) patient cohorts were compared over a 9-year period.
  • Reoperative patients presented with similar demographics but higher rates of clinical instability (NYHA class 4).
  • Internal mammary artery (IMA) use was significantly lower in primary CABG patients who later required reoperation compared to primary CABG alone.

Purpose of the Study:

  • To compare outcomes of primary versus reoperative coronary artery bypass grafting.
  • To identify predictors of perioperative mortality in both primary and reoperative CABG.
  • To evaluate the long-term effectiveness of reoperative CABG.

Main Methods:

  • Analysis of 2645 primary CABG and 458 reoperative CABG patients.
  • Comparison of preoperative risk factors, intraoperative variables, and postoperative outcomes.
  • Assessment of long-term survival and cardiac event-free rates after reoperative CABG.

Main Results:

  • Reoperative CABG had higher operative mortality (9.2% vs. 2.3%) and morbidity (e.g., myocardial infarction, ventilatory support).
  • Mortality risk increased significantly when reoperation occurred within 1 year of the initial surgery (28% vs. 8.4%).
  • Predictors of mortality included emergency operation, NYHA class 3-4, poor left ventricular function, and left main stem stenosis in reoperative cases.

Conclusions:

  • Reoperative CABG is a viable option, offering long-term survival and symptom improvement.
  • Increased operative risk in reoperative CABG is associated with clinical instability, left main stem stenosis, and impaired left ventricular function.
  • Optimizing IMA graft utilization in initial surgeries may impact reoperation outcomes.

Related Concept Videos